Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
Pancreatic cancer (PC) is burdened with a low 5-year survival rate and high mortality due to a severe lack of early diagnosis methods and slow progress in treatment options. To improve clinical diagnosis and enhance the treatment effects, we applied metabolomics using ultra-high-performance liquid c...
Main Authors: | Chang Liu, Henan Qin, Huiying Liu, Tianfu Wei, Zeming Wu, Mengxue Shang, Haihua Liu, Aman Wang, Jiwei Liu, Dong Shang, Peiyuan Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.991051/full |
Similar Items
-
High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma
by: Yufei Zhu, et al.
Published: (2022-10-01) -
The expression landscape of cachexia‐inducing factors in human cancers
by: Paula Paccielli Freire, et al.
Published: (2020-08-01) -
In Silico and In Vitro Analysis of lncRNA XIST Reveals a Panel of Possible Lung Cancer Regulators and a Five-Gene Diagnostic Signature
by: Periklis Katopodis, et al.
Published: (2020-11-01) -
TCF/LEF Transcription Factors: An Update from the Internet Resources
by: Dusan Hrckulak, et al.
Published: (2016-07-01) -
A Nucleotide Metabolism-Related Gene Signature for Risk Stratification and Prognosis Prediction in Hepatocellular Carcinoma Based on an Integrated Transcriptomics and Metabolomics Approach
by: Tianfu Wei, et al.
Published: (2023-10-01)